The activated BAFF and BCMA (Kim et al., 2011; Vincent et al., 2013) may be the main potential pathogenesis of secondary SS, as four subjects with systemic lupus erythematosus and one with systemic sclerosis. This evidence concerns the gene TNFRSF17 and systemic sclerosis.